SE447261B - Nya tripeptidamider, som inverkar pa det centrala nervsystemet - Google Patents

Nya tripeptidamider, som inverkar pa det centrala nervsystemet

Info

Publication number
SE447261B
SE447261B SE8004744A SE8004744A SE447261B SE 447261 B SE447261 B SE 447261B SE 8004744 A SE8004744 A SE 8004744A SE 8004744 A SE8004744 A SE 8004744A SE 447261 B SE447261 B SE 447261B
Authority
SE
Sweden
Prior art keywords
pro
mmol
solution
dissolved
evaporated
Prior art date
Application number
SE8004744A
Other languages
English (en)
Swedish (sv)
Other versions
SE8004744L (sv
Inventor
L Kisfaludy
T Szirtes
L Balaspiri
E Palosi
L Sporny
A Sakardi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8004744L publication Critical patent/SE8004744L/xx
Publication of SE447261B publication Critical patent/SE447261B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8004744A 1979-06-28 1980-06-26 Nya tripeptidamider, som inverkar pa det centrala nervsystemet SE447261B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI717A HU180925B (en) 1979-06-28 1979-06-28 Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem

Publications (2)

Publication Number Publication Date
SE8004744L SE8004744L (sv) 1980-12-29
SE447261B true SE447261B (sv) 1986-11-03

Family

ID=11001100

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004744A SE447261B (sv) 1979-06-28 1980-06-26 Nya tripeptidamider, som inverkar pa det centrala nervsystemet

Country Status (21)

Country Link
US (1) US4299821A (fi)
JP (1) JPS5636442A (fi)
AT (1) AT373578B (fi)
AU (1) AU538100B2 (fi)
BE (1) BE884014A (fi)
CA (1) CA1151154A (fi)
CH (1) CH650518A5 (fi)
CS (1) CS239907B2 (fi)
DD (1) DD151746A5 (fi)
DE (1) DE3024313A1 (fi)
DK (1) DK149611C (fi)
FI (1) FI74473C (fi)
FR (1) FR2460292A1 (fi)
GB (1) GB2058080B (fi)
HU (1) HU180925B (fi)
IL (1) IL60407A (fi)
IT (1) IT1150023B (fi)
NL (1) NL8003767A (fi)
PL (1) PL127100B1 (fi)
SE (1) SE447261B (fi)
SU (1) SU963463A3 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533209B1 (fr) * 1982-09-22 1985-11-08 Centre Nat Rech Scient Lipopeptides, leur obtention et leur application comme emulsifiants
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
IT1186733B (it) * 1985-06-05 1987-12-16 Eniricerche Spa Composti tripeptidici ad azione ipotensiva
FR2597100A1 (fr) * 1986-01-21 1987-10-16 Nippon Shinyaku Co Ltd Derives du pyroglutamide
US5494919A (en) * 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
CZ134296A3 (en) * 1993-11-09 1996-12-11 Merck & Co Inc Piperidine, pyrrolidine and hexahydro-1h-azepine derivatives, process of their preparation and pharmaceutical compositions containing thereof
FR2733995B1 (fr) * 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments
DE19527575A1 (de) * 1995-07-28 1997-01-30 Basf Ag Verfahren zur Herstellung von peptidischer Wirkstoffe
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US20050233973A1 (en) * 1997-10-09 2005-10-20 Albert Sattin Tri-peptides for antidepressant applications
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
LU73294A1 (fi) * 1975-09-02 1977-05-11

Also Published As

Publication number Publication date
AU538100B2 (en) 1984-07-26
GB2058080B (en) 1983-02-23
IT8023096A0 (it) 1980-06-26
DK149611C (da) 1987-01-26
PL225268A1 (fi) 1981-10-16
DE3024313A1 (de) 1981-01-29
HU180925B (en) 1983-05-30
FR2460292B1 (fi) 1983-11-18
GB2058080A (en) 1981-04-08
FI74473B (fi) 1987-10-30
DK274680A (da) 1980-12-29
ATA334680A (de) 1983-06-15
CS239907B2 (en) 1986-01-16
US4299821A (en) 1981-11-10
IT1150023B (it) 1986-12-10
PL127100B1 (en) 1983-09-30
JPS5636442A (en) 1981-04-09
DK149611B (da) 1986-08-11
FI74473C (fi) 1988-02-08
CS458480A2 (en) 1985-05-15
AT373578B (de) 1984-02-10
NL8003767A (nl) 1980-12-30
FI802057A (fi) 1980-12-29
FR2460292A1 (fr) 1981-01-23
IL60407A0 (en) 1980-09-16
SE8004744L (sv) 1980-12-29
CH650518A5 (de) 1985-07-31
DE3024313C2 (fi) 1991-05-29
SU963463A3 (ru) 1982-09-30
DD151746A5 (de) 1981-11-04
AU5971980A (en) 1981-01-08
BE884014A (fr) 1980-12-29
CA1151154A (en) 1983-08-02
IL60407A (en) 1984-11-30

Similar Documents

Publication Publication Date Title
EP0462884B1 (fr) Dérivés de TRH, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
NL192575C (nl) Op het centrale zenuwstelsel werkende tripeptiden.
JPS6113480B2 (fi)
EP0109418A1 (en) Gonadoliberin derivatives, process for the preparation and pharmaceutical and veterinary compositions thereof
SE447261B (sv) Nya tripeptidamider, som inverkar pa det centrala nervsystemet
JPS5973574A (ja) 環状ジペプチド類
JPS6345398B2 (fi)
US4124703A (en) Luliberin analogs
DE3446997A1 (de) Gonadoliberinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel beziehungsweise pharmazeutische praeparate
US4491541A (en) Peptides
Jones Jr et al. Simple, high yield synthesis of arginine vasopressin
JPS60231697A (ja) ペプチド
FR2595705A1 (fr) Derives de gonadoliberine contenant un acide aminocarboxylique aromatique en position 6, compositions pharmaceutiques et veterinaires les contenant et procede pour les preparer
GB2130590A (en) Peptides
US3341510A (en) L-alanyl-l-phenylalanyl-l-isoleucyl-glycyl-l-leucyl-l-methioninamide and a protectedderivative thereof
US3931138A (en) N-carbobenzoxy-pyroglutamyl-histidine
SU1095588A1 (ru) Циклический аналог энкефалина, обладающий анальгетической активностью
SU1182796A1 (ru) Аналог энкефалина, обладающий анальгетической активностью
RU2043769C1 (ru) Способ получения пептида
BE898198A (fr) Peptides biologiquement actifs, procédé pour leur préparation et leur emploi comme médicaments.
JPH0322398B2 (fi)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8004744-2

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8004744-2

Format of ref document f/p: F